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Abstract
Background: Garlic and Zataria multiflora boiss (ZMB) are herbal medicines used traditionally in the treatment of infections, including candidal vaginitis.
Objectives: This study aimed to examine the effect of garlic and ZMB vaginal cream 2%, in the treatment and recurrence of candidal vaginitis.
Methods: This randomized, double-blinded clinical trial was conducted on 240 married women with candidal vaginitis. The patients used 5 gr garlic, ZMB or clotrimazole
vaginal cream 2% daily, for 7 days. Complaints of the patients, clinical observations and laboratory parameters were recorded before treatment, on days 7 and 30, after
treatment. The data were analyzed by SPSS v. 21 through chi-square, Fisher, ANOVA with repeated measures, McNemar and Kruskal-Wallis tests. A P <0.05 was considered
significant.
Results: Before treatment, all patients had positive candidiasis fungi culture, in both groups (100%). The positive culture was 14.1%, 15.2%, 10.3%, respectively, on day 7
after treatment and 2.6%, 0%, 0% on day 30, after treatment with garlic, ZMB and clotrimazole, respectively (P < 0.001). No significant differences were observed between
groups on days 7 (P = 0.69) and 30 (P = 0.21) after treatment, in culture results. There were no significant differences between groups, in terms of patient complaints and
clinical observations before intervention, at days 7 and 30 after treatment (P > 0.05). Mean scores of candidal symptoms reduced significantly in all groups at on 7 and
30, after treatment (P < 0.001).
Conclusions: Garlic and ZMB vaginal cream 2% can be used as an effective treatment option in cases of drug resistance and, also, by the people who are interested in
treating with herbal medicines.
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1. Background
Candidal vaginitis is the second most common vaginal
infection (1, 2). Studies conducted in Iran have shown that
41.3% of women have had vaginal infections and the most
common cause of vaginitis was candida (47.4%) (3). Since
this infection causes problems such as depression, low self-
esteem, life dissatisfaction, increased stress and decreased
sexual relations in women, it is therefore necessary to be-
gin treatment early (4).
There are several treatments for candidal vaginitis, in-
cluding drugs like topical and oral azoles (5). The success
of the treatment with these drugs is almost 80% (6). Oral
azole drugs have several side effects, such as dizziness, nau-
sea, vomiting, abdominal pain, diarrhea and headache and
are mostly contraindicated during pregnancy and lacta-
tion (7, 8). A certain degree of drug resistance has been re-
cently reported (9-11).
According to the side effects of the chemical drugs,
consumption of herbal drugs has been common (12). In
several studies it has been observed that many plants con-
tain substances that have effect on bacteria, viruses and
fungi (13). Among these, garlic is one of the oldest drugs
used to treat various diseases. Active ingredients of garlic
include alliine, allicine and derivatives of allicine, as ajoene
and dithiin (14).
Micosin vaginal cream (50 grams), containing extracts
of garlic 1: 1000 and Zataria multifloraboiss (ZMB) is avail-
able on the Iran market (15). In Ardebil, this herbal plant is
used in different forms to treat different types of diseases,
such as vaginitis, and most people are satisfied with its use
(13).
The ZMB is a type of mint family (Lamiaceae). The
essential oil contains 25-40% phenol, with considerable
amounts of thymol and a small amount of carvacrol.
Other compounds include parasmin, bornyl, linalool and
β-pinene. The thymol and carvacrol of ZMB have antifun-
gal (Candida) effect (16). In Iran, ZMB vaginal cream is pro-
duced based on 0.027-0.033% thymol, branded as Leucorex,
by Bariji Essence Company and it has antibacterial and can-
didiasis effects (17). It is traditionally used to treat vaginal
infections. If consumed in small amounts, these medicinal
herbs have no side effects (18). A clinical study by Fouladi
et al. showed that the effects of the ZMB (1%) vaginal cream
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are similar to clotrimazole (19). In the study of Kordi et al.,
the effects of vaginal garlic extract (1%) douche was inferior
to clotrimazole cream 1% (20). Bahadoran et al. indicated
that the effects of vaginal cream containing garlic (1: 1000)
and thyme are similar to clotrimazole (21). In the study of
Fardyazar et al., the response to treatment and reduction
in recurrence rate of vulvovaginal candidiasis were simi-
lar among fluconazole and long-term users of azole vagi-
nal creams (22). Goncagul et al. indicated that garlic and
ZMB act against bacterial, viral, mycotic and parasitic infec-
tions. It is also known that garlic is a wonderful plant, hav-
ing the properties of empowering immune system, anti-
tumor and antioxidant effects (13). In the study of Jafari
et al., ZMB essence, at concentrations of 50 and 25 mg/mL,
effectively removed Candida cells that had adhered to the
denture surface, similar to the level of removal observed
for 100000 IU nystatin (23).
2. Objectives
Since there are no clinical studies, which compare the
effects of the three therapies of garlic, ZMB and clotrima-
zole, simultaneously, while, on the other hand, we did not
find any clinical study to survey the effect of garlic 2% and
ZMB 2% and there is a great amount of inconsistency be-
tween the results of existing trials, the present study aimed
to compare the effect of the garlic 2%, ZMB 2% and clotrima-
zole 2% vaginal cream in the treatment and recurrence of
candidal vaginitis.
3. Methods
The present research is a double blind clinical trial that
was performed on 240 patients referred to Ardabil Alavi
governmental and referral hospital center, Ardabil, Iran,
from October 2013 to January 2014. The research was reg-
istered with code IRCT201305276709N12 in IRCT and ap-
proved by the Regional Ethics Committee of Tabriz Uni-
versity of Medical Sciences (9253), Tabriz, Iran. Inclusion
criteria consisted of married women aged 18 - 49 years,
who had candidal vaginitis, accessibility to telephone and
were literate. Exclusion criteria included use of immuno-
suppressive drugs, antibiotics, vaginal medications dur-
ing the past 2 weeks, the risk of autoimmune diseases,
breast feeding, pregnancy, chronic diseases and hypothy-
roidism, organ transplantation, Gardnerella vaginalis, Tri-
chomonas vaginalis, post-menopausal women, history of
abortion or childbirth less than 6 weeks, history of chronic
candidiasis, allergy to clotrimazole.
Data collection instruments included socio-
demographic and fertility characteristics, patient com-
plaints and clinical observations and laboratory tests. The
socio-demographic and fertility characteristics question-
naire included age, education level, occupation, number
of pregnancies, abortions, currently used contraception
methods of patients.
The validity was determined as content validity. A re-
searcher and coresearcher examined separately the vagi-
nal discharge of 10 patients, to determine the reliability. In
this study, the Spearman correlation coefficient was mea-
sured as r = 0.835. Also, among 10 patients, two samples
were prepared separately and were sent to the laboratory
under two different names, to verify the similarity of the
results.
We used Tomy SX-700e autoclave (Tomy Seiko Co. Ltd.,
Tokyo, Japan) to autoclave culture. Sabouraud dextrose
agar with chloramphenicol was used to prepare cultiva-
tion. Olympus CXZ1FS1 microscope (Tokyo, Japan) was ap-
plied for visual identification of Candida in vaginal dis-
charge. We used SANY laboratory incubator Netherlands
120, nl4879 for Candida growth for 48 hours, at an ambient
temperature of 30°C.
Sample size was considered 80 patients in each group,
after comparison of the ratios and assuming α = 0.05, β =
20% and taking into consideration the recovery rate in Fu-
ladi et al. study, in the group receiving clotrimazole 47.4%,
in the group receiving ZMB 54.3%, and in Kordy et al. study
the group receiving clotrimazole 57% and the group receiv-
ing garlic 34%, by considering the loss of 10% of partici-
pants (19, 20). Then we used the larger calculated samples.
(1)n =
(u+ v)2P1 (100− P1)+P2 (100− P2)
(P1 − P2)2
The women who complained from vulvovaginal pru-
ritus and discharge completed the questionnaire of de-
mographic and fertility characteristics, complaints of pa-
tients and severity of disease, through the interview, af-
ter a full explanation of the objectives and methodology.
Informed consent was obtained before the completion of
questionnaires. Each symptom (cheesy discharge, pruri-
tus, edema, erythema, irritation during intercourse, pain
during intercourse) was scored between 0 and 3, based on
severity for determination of the infection level, as follows:
(0 - 2) = no, (3 - 8) = mild, (9 - 13) = medium, (14 - 18) = severe.
The patients should obtain a minimum score of 3, out of 18,
to be eligible for the study.
In patients with signs of candidiasis, vaginal discharge
samples were taken from the posterior fornix, by three ster-
ile swabs. The discharges on the first swab specimens were
placed on a clean slide for whiff testing, then one or two
drops of potassium hydroxide 10% were added, being ex-
amined afterward regarding the amine odor and studied
under a microscopic slide in the presence of yeast cells. The
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second swab discharges were placed in a test tube contain-
ing 1 mL normal saline for wet mount test and gram stain-
ing, for observing clue cells and Trichomonas. The third
swab was hold in sabouraud dextrose agar chlorampheni-
col, for fungal cultures, for 48 h at 30°C and, in the case of
growth of the fungus in the dextrose agar plate, the culture
was considered positive. All samples were examined by a
professional laboratory expert, without knowledge of the
results of clinical examinations. When the whiff and wet
test were negative and symptoms of candida were mild,
treatment was delayed until preparing the gram staining
test and fungal culture and, when all mentioned tests con-
firmed the candida infection and that was concomitantly
negative from Trichomonas and Gardenella, the treatment
was begun.
Garlic and ZMB were purchased from a reliable per-
son and then identified by an expert of the Herb research
center, Tabriz University of Medical Sciences, Tabriz, Iran,
and were further registered in the herbarium of this cen-
ter. They were soaked in a solution of ethanol 70% and
then stirred for 72 hours in the shaker of the Laboratory
of Pharmaceutics, School of Pharmacy, Tabriz University
of Medical Sciences, Tabriz, Iran, under the direction of a
pharmacist. The solutions were filtered and the residuum
was poured again into ethanol solution and stirred for 72
hours. Then, the extract was removed and added to the first
extract and the final extracts were placed on the operator
rotary at 40°C, to prepare powders obtained by grinding
the particles. The powders were milled and, for prepara-
tion of vaginal creams, sodium carboxymethyl cellulose 4%
was used. The protected water was prepared using methyl
and propyl parabens and appropriate amount of the pow-
ders were added to water and stirred until they completely
dissolved and dispersed. The sodium carboxymethyl cellu-
lose was added and the mixture was stirred until suitable
viscosity vaginal creams 2% were achieved. The prepared
vaginal creams were added drops of normal phosphoric
acid until, up to a pH = 4. Obtained vaginal creams were
placed in the filling machine and poured into sterile tubes,
without a name.
Firstly, participants were sampled connivance. Partici-
pants with vaginal pruritus, who referred to this center, af-
ter confirmatory laboratory test (candidal vaginitis), were
selected as sample for research. The participants were di-
vided randomly, into three groups, through a computer
random numbers table and block randomization, with
block sizes of 3 and 6, with allocation ratio of 1:1:1. They
received garlic, ZMB or clotrimazole vaginal cream. The
tubes contained 40 grams of garlic (the garlic odor, after
preparation of the vaginal cream, was very low or, in sev-
eral cases, undetectable by human smell), ZMB or clotrima-
zole vaginal cream that were similar in shape, color and
size and were placed in the sealed non-transparent pock-
ets, separately, by a person which was uninvolved in re-
search, according to the allocation sequence, and each par-
ticipant received one pocket, numbered consecutively. In-
formed consent was obtained before drug delivery.
Minimum inhibitory concentration (MIC) testing of
candidates, for the 40 subjects, according to the Clinical
and Laboratory Standards Institute M27-A2 Section 3 [1],
was performed. Dilutions of 1%, 2% and 4% of garlic and
ZMB extract were prepared. Based on the results of MIC,
garlic and ZMB, with a concentration of 2%, were chosen.
Due to the ethical consideration of the application of the
garlic and ZMB vaginal cream 2% for the first time in this
study, for ensuring a minimization of the risk of allergy in
the patients, at first, a dental hygiene solution of these ex-
tracts was tested, for 2 minutes, and oral examination was
performed immediately and 15 minutes after washing. Af-
terward, the patients were prescribed a vaginal cream.
The patients were advised to apply the creams in a sin-
gle application (5 gr), every night, for 7 nights, to reach the
full depths of the vagina, as well as to avoid intercourse
without condom, douching and antibiotic drugs and use
hygienic underwear and continue the treatment during
menstruation. The participants were asked to complete
the checklist of the relief of symptoms and improvement
(five levels of improvement). The participants were in-
vited to the clinic 7 days after treatment, to complete the
checklist of side effects of garlic, ZMB and clotrimazole.
Also, they were examined and the samples of secretion
were taken for microscopic inspection and subculture, one
week and 4 weeks after completion of treatment, to assess
satisfaction and the rate of recovery.
The success of treatment in this study was defined as a
negative culture of vaginal discharge and reduction of the
severity of symptoms (from grade 2, 3 to grade 1 or zero). In
case of absence of curing, treatment was continued with
clotrimazole vaginal cream.
3.1. Statistical Analysis
Data were analyzed using v. 21 (SPSS Inc., Chicago,
IL, USA). Normality of the quantitative variable for each
group was reviewed and upheld through Kolmogorov-
Smirnov descriptive test. To describe demography, fertil-
ity, personal-social characteristic, clinical and laboratory
result, descriptive statistics including mean (standard de-
viation) and frequency (%) were used. Also, to assess the
relationship between demography and fertility, personal-
social, clinical and laboratory results, and relief of symp-
toms and improvement in the intervention group, chi-
square, Fisher’s exact test, ANOVA with repeated measure
and Kruskal-Wallis tests were used. Significance level was
set at P < 0.05.
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Figure 1. Flow Chart of the Trial Comparing the Effectiveness of a Vaginal Cream Based on Garlic, Zataria multifloraboiss and Clotrimazole in Improving Fungal Vaginitis
4. Results
In this trial, 240 women (80 garlic, 80 ZMB and 80
clotrimazole cases) with candidal vaginitis were studied.
One week after the procedure, five participants (two of gar-
lic group, one of the ZMB group and two of the clotrima-
zole group) were excluded, due to lack of willingness to
continue treatment and the remaining 235 patients were
examined. Participants were followed up clinically and
laboratory at one and 4 weeks after the intervention.
Most women were in age group of 34-39 years old, most
of them were housewives (80%) and had under diploma
education level (60%), while the number of their previ-
ous pregnancies was 2-3. Most participants used intrauter-
ine device to prevent pregnancy (40%). Their husbands,
job was mostly self-employee. Three groups were similar
in socio-demographic and fertility characteristics, such as
age, education level, occupation, number of pregnancies
and currently used contraception methods (P > 0.05) (Ta-
ble 1).
Before treatment, the most common clinical com-
plaint in the garlic, ZMB and clotrimazole groups was pru-
ritus, accounting for 96.2%, 100% and 98.7%, respectively.
The recovery rates on day 7 after treatment was 84.7%, 84.8%
and 85.9% and at 30 days after treatment were 94.9%, 98.7%
and 100%, in garlic, ZMB and clotrimazole groups, respec-
tively. There was no significant difference between the
three groups at baseline, 7 and 30 days after treatment
(P0 = 0.32, P1 = 0.83, P2 = 0.61, respectively). In relation
to clinical observations, almost all patients in the garlic,
ZMB and clotrimazole groups had vulvovaginal erythema
(100%, 97.5% and 98.8%, respectively). The recovery rate on
days 7 and 30 after treatment were 82.1%, 70.9%, 84.7% and
97.4%, 96.2%, 96.2%, respectively. No significant difference
was observed between groups at baseline, days 7 and 30
after treatment (P0 = 0.77, P1 = 0.13, P2 = 0.74). Other com-
plaints and clinical observation of the patients at three
time points between groups showed no significant differ-
ence (Table 2). In laboratory examinations, all participants
were positive in candida fungi culture and the rate of re-
covery was reported as 85.9% and 97.4% in garlic, 84.8% and
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Table 1. Comparison of Socio-Demographic and Obstetric Characteristicsa , b
Socio-Demographic andObstetric Characteristics Zataria multifloraboiss (n = 80) Garlic Clotrimazole (n = 80) P
Age, y
15 - 24 5 (6.2) 5 (6.2) 6 (7.5) 0.65*
25 - 29 13 (16.2) 11 (13.8) 14 (17.5)
30 - 34 18 (22.5) 15 (18.8) 11 (13.8)
35 - 39 26 (32.5) 24 (30) 26 (32.5)
> 40 18 (22.5) 25 (31.5) 23 (28.8) 0.59†
Education level
Primary school 10 (12.5) 17 (21.2) 18 (22.5)
Secondary school 10 (12.5) 22 (27.5) 18 (22.5) 0.37§
High school 28 (35) 34 (42.5) 25 (31.2)
University 29 (36.2) 7 (8.8) 22 (27.5)
Occupation
Housewife 73 (91.2) 73 (91.2) 66 (82.5) 0.2*
Employee 7 (8.8) 7 (8.8) 14 (.17.5)
Number of pregnancy
No pregnancy 4 (5) 4 (5) 5(6.2)
1 - 3 63 (82.9) 55 (72.4) 55(73.3) 0.71*
> 4 13 (17.1) 22 (26.7) 20(26.7)
Mean (SD) 2.4 (1.2) 2.8 (1.5) 2.6 (1.4) 0.45†
Type of delivery
Natural 4 (5) 30 (37.05) 5(6.2) 0.63*
Cesarean 30 (37.5) 46 (57.5) 33 (41.2)
Without delivery 47 (58.8) 4 (5) 42 (52.2)
Curettage history 11 (13.8) 22 (27.5) 21 (26.2) 0.12 ƒ
The last delivery
< 3 23 (33.8) 16 (21.1) 18 (24) 0.21 ƒ
> 3 57 (76) 60 (78.9) 51 (66.2)
Mean (SD) 4.88 (2.8) 5.36 (3.5) 5.06 (3) 0.7†
Current ContraceptionMethods
OCPs 2 (2.5) 0 4 (5)
Condom 8 (10) 8 (10) 5 (6.2) 0.45*
IUD 36 (45) 33 (41.2) 34 (42.5)
Withdrawal 21 (26.2) 21 (26.2) 15 (8.18)
TL 8 (10) 11 (13.8) 41 (17.5)
None 5 (6.2) 6 (7.5) 8 (10)
Abbreviations: IUD, Intrauterine Device; OCPs, Oral Contraceptive Pills; TL, Tubal Ligation.
aAll numbers, with the exception of those specified, are displayed as the prevalence (percentage).
bChi-square test*, independent T-square test, Fisher’s exact test ƒ.
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100% in ZMB group and 89.7% and 100% in clotrimazole
group, respectively. There were statistically significant dif-
ferences in terms of recovery rate, based on culture results,
in the three groups between baseline, 7 and 30 days after
treatment (P < 0.001). Also, other laboratory parameters
showed statistically significant differences between base-
line, 7 and 30 days after intervention. The recovery process
continued 30 days after treatment in all groups and no re-
currence was reported (Table 3).
The survey on the relief symptoms and improvement
showed that improvement level on the seventh day was in
level 5, in more than 79%. However, this was not statistically
significant (P = 0.21) (Table 4).
Mean (SD) scores of candidiasis symptoms reduced sig-
nificantly on days 7 and 30, after treatment (P < 0.001) (Ta-
ble 5).
Comparison of the Mean (SD) scores of candidal vagini-
tis symptoms in three groups at baseline, days 7 and 30 af-
ter intervention were shown in Figure 2.
Candidal Vaginitis
Groups
ZMB
Clotrimazole
Garlic
Time
Baseline    7Days After Intervention  30 Days After
Intervention
M
ae
n
 S
co
re
12.00
10.00
8.00
6.00
4.00
2.00
.00
Figure 2. The Mean Scores of Candida Vaginitis Symptoms at Baseline, 7 and 30 Days
After Intervention
Although three of the participants in the ZMB group re-
ported irritation on the first day of use and two patients
complained of garlic smell and had nausea on the first day,
these inconveniences did not prevent the use of drugs.
5. Discussion
The recovery rates in garlic, ZMB and clotrimazole
groups, on days 7 and 30 after treatment, based on the re-
sults of the agar, were 85.9%, 84.8%, 89.7%, and 97.4%, 100%,
100%, respectively. In this study, the recovery rate of garlic
and ZMB was similar to clotrimazole vaginal cream.
Kordi et al. (20) have shown a similar improvement,
based on culture for 7 days after treatment, in the gar-
lic and clotrimazole group, with 40.8% and 60.8%, respec-
tively. This is inconsistent with our study. More concentra-
tion of active substances in our research (2%) is a possible
reason for higher improvement.
Bahadoran et al. (21) have shown that vaginal cream,
containing garlic and thyme, is as effective as clotrimazole
vaginal cream, for the treatment of candida vaginitis. In
the Fouladi research, at 7 days after treatment, recovery
percentage (negative laboratory test) in ZMB was 97% and
it was 100% with clotrimazole (19). The results of this study
are inconsistent to our study, in terms of negative culture
at day 7. This difference may result from the difference in
the severity of symptoms. However, in our study, the recov-
ery rate, based on the culture at day 30 in the three groups
was between 97.4% and 100%. In the Fouladi study, there
was no statistically significant difference between the two
groups, in terms of recovery based on the culture, com-
pared to the present study (19).
The effect of ZMB vaginal cream 2% in reduction of
symptoms of candida was greater compared to the 1%
cream used in the Fouladi study (19). In our study, com-
plete improvement of symptoms, in more than 79% of the
participants, was reported at day 7. Candida symptoms im-
provement was similar in all groups. However, in the study
of Fouladi et al., improvement was reported at day 7 after
treatment in the ZMB group in 54.3% of participants and
in the clotrimazole group in 47.4% (19). In our study, re-
currence was observed only in two (2.6%) women in garlic
group, 30 days after treatment. However, the recurrence
rate was not assessed after 30 days by Fouladi et al. and
Bahadoran et al. (19, 21). Fardyazar et al. have shown that
the recurrence rate in the follow-up period (first 6 months)
was 8.6% in fluconazole and 8.5% in clotrimazole group. Re-
currence rate in the extended follow-up period (further 6
months) was 38.3% and 40%, respectively (NS) (22).
Kordi et al. reported that complete improvement of
symptoms, at day 7 after treatment, in the garlic group, was
51% and in the clotrimazole group was 66.7% (20).
Naeini et al. investigated 50 plant extracts effects on
candidosis and showed that thyme and lavender have a
very strong antifungal effect (24). Laboratory studies have
shown that certain herbs, like ZMB and geranium, also
have antimicrobial effect, similar to azole drugs (25).
Jafari et al. indicated that Zataria essence, at concentra-
tions of 50 and 25 mg/mL, removed 100% of attached Can-
dida cells that had adhered to the denture surface, similar
to the level of removal observed for 100000 IU nystatine
(minimum fungicidal concentration). In this study, 12.5
mg/mL concentration of ZMB was considered as the MIC90
(23).
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Table 2. Comparison of the Patient Complaints and Clinical Observations Between Groups at Baseline, 7 and 30 Days After Treatmenta
Groups Garlic Zataria multiflora Clotrimazole P0 P1 P2
Pre-
treatment
(n = 80)
7 Days After
Treatment
(n = 78)
30 Days
After
Treatment
(n = 78)
Pre-
treatment
(n = 80)
7 Days After
Treatment
(n = 79)
30 Days
After
Treatment
(n = 79)
Pre-
treatment
(n = 80)
7 Days After
Treatment
(n = 78)
30 Days
After
Treatment
(n = 78)
Complaints
Cheesy
discharge
66 (82.5) 1 (1.3) 0 66 (82.5) 2 (2.6) 0 62 (77.5) 0 0 0.67 0.77 1
Pruritus 77 (96.2) 9 (11.5) 1 (1.3) 80 (100) 12 (15.2) 1 (1.3) 79 (98.7) 10 (12.8) 0 0.32 0.83 0.61
Urine
irritation
28 (35) 0 0 28 (35) 1 (1.3) 0 27 (33.8) 0 0 1 0.37 1
Irritation
in inter-
course
45 (5.56) 0 0 42 (52.5) 4 (5.1) 1 (1.3) 39 (48.8) 3 (3.8) 0 0.65 0.16 0.37
Pain in in-
tercourse
70 (87.5) 8 (10.3) 0 73 (91.2) 9 (11.6) 0 72 (90) 10 (11.8) 0 0.80 0.90 1
Clinical
observations
Vulvovagi-
nal
erythema
80 (100) 14 (17.9) 2 (2.6) 78 (97.5) 21 (26.6) 1 (1.3) 79 (98.8) 11 (14.1) 0 0.77 0.13 0.74
Unnatural
cervical ap-
pearance
72 (90) 2 (2.6) 2 (2.6) 12 (15) 2 (2.5) 1 (1.3) 8 (10) 3 (3.8) 2 (2.6) 0.55 0.90 0.84
Inflamma-
tion of the
vaginal
80 (100) 16 (20.5) 4 (5.1) 78 (97.5) 22 (27.8) 4 (5.1) 79 (98.8) 16 (20.5) 1 (1.3) 0.77 0.48 1
Unnatural
discharge
(82.5) 66 4 (5.1) 2 (2.6) 62 (77.5) 6 (7.6) 3 (3.8) 62 (77.5) 4 (5.1) (5.1) 0.69 0.83 0.52
Non-
homogenous
discharge
67 (86.2) 4 (5.1) 2 (2.6) 64 (80) 5 (6.3) 1 (1.3) 69 (86.8) 1 (1.3) 5 (6.4) 0.59 0.35 0.84
Nontrans-
parent
discharge
Appear-
ance
70 (87.5) 5 (6.4) 0 66 (82.5) 7 (8.8) 0 70 (87.5) 2 (2.6) 1 (1.3) 0.60 0.27 0.55
Discharge color
Grey 1 (1.2) 4 (5.1) 0 0 4 (5.1) 0 0 1 (1.3) 0 41 40 0.62
Cheesy 70 (87.5) 0 1 (1.3) 65 (81.2) 0 0 70 (87.5) 1 (1.3) 0
Colorless 9 (11.2) 74 (94.9) 77 (100) 15 (18.8) 75 (94.9) 79 (100) 10 (12.5) 76 (97.4) 78 (100)
Abbreviations: P0 , Before Intervention; P1 , 7 Days After Intervention; P2 , 30 Days After Intervention.
a Fisher’s exact test was used for comparison.
The comparison of the results of this study with other
studies depicts more reduction of complaints after treat-
ment with garlic vaginal cream 2% and ZMB vaginal cream
2%. The most common symptom was pruritus. In the study
by Fouladi et al., pruritus was common and 7 days after
treatment improvement was reported in 80% of the partic-
ipants in ZMB group and 71% in the clotrimazole group (19).
In the Fouladi et al. research, the complaints on the
cheesy discharge in the ZMB and clotrimazole groups, be-
fore treatment, were present in 100% of patients before
intervention and at day 7 after treatment the rate was re-
duced to 40% and 42.1%, respectively (19). Perhaps, the high
percentage of the effective substance in the vaginal cream
2%, in comparison with 1%, is more adequate in terms of the
patient complaint reduction. There was no follow up at day
30 after treatment in the Fouladi et al. study (19).
There was no difference between the relief of symp-
toms and improvement level between groups. The major-
ity of the participants in the groups of garlic (79.5 %), ZMB
(81%) and clotrimazole (82.1%) had complete recovery on
the 7th day and there were no significant differences be-
tween the three groups (P = 0.21). In Bahadoran et al. study,
the effect of garlic and thyme vaginal cream group was the
same as clotrimazole (21). In Fouladi et al. study, the com-
plete recovery was 54.3% in ZMB (1%) group and 47.4% in
clotrimazole groups, respectively (19). These studies are in-
consistent to our study. Probably, the difference is due to
the low number of patients in their study and difference
in concentration of drug. Vicariotto et al. showed that
natural substances are more relieving than chemical sub-
stances in candidiasis symptoms (26).
One of the strong points of this study is the application
of garlic and ZMB 2% in the treatment of candidal vagini-
tis, higher sample size and, also, follow-up for 30 days after
treatment for recurrence.
However, this study had several limitations. We did
Iran Red Crescent Med J. 2016; 18(12):e29262. 7
Farshbaf-Khalili A et al.
Table 3. Comparison of Laboratory Results Between and Within Groups at Baseline, 7 Days and 30 Days After Treatmenta , b
Laboratory Results Groups Time of Study 7 Days After Treatment 30 Days After Treatment P * P ** P ***
Positivewetmount test
ZMB 76 (95) 18 (22.8) 1 (1.3) < 0.001 < 0.001 < 0.001
Clotrimazole 80 (100) 14 (17.9) 0 < 0.001 < 0.001 < 0.001
Garlic 79 (98.7) 12 (15.4) 1.3 < 0.001 < 0.003 < 0.001
P0 0.18 ƒ 0.29* 0.60 ƒ
Positive Gram stain
ZMB 54 (67.5) 0 0 < 0.001 < 0.001 < 0.001
Clotrimazole 57 (71.2) 1 (1.3) 0 < 0.001 < 0.001 < 0.001
Garlic 62 (77.5) 5 (6.4) 0 < 0.001 < 0.001 < 0.001
P1 0.38* 0.02 ƒ 1 ƒ
Positive culture in agar
ZMB 80 (100) 12 (15.2) 0 < 0.001 < 0.001 < 0.001
Clotrimazole 80 (100) 8 (10.3) 0 < 0.001 < 0.001 < 0.001
Garlic 80 (100) 11 (14.1) 2 (2.6) < 0.001 < 0.004 < 0.001
P2 1 ƒ 0.69* 0.21 ƒ
Abbreviations: P0 , Before Intervention; P1 , 7 Days After Intervention; P2 , 30 Days After Intervention.; ZMB, Zataria multiflora boiss.
aP *, P **, P ***: Neymar MAC test for the comparison of the group garlic, ZMB and clotrimazole.
bFisher exact test ƒ and chi square test *were used for comparison between groups.
Table4. Comparison of the Relief of Symptoms and Improvement in the Three Intervention Groups Receiving Vaginal Cream (Garlic, Zataria multiflora boiss and Clotrimazole)
After consumption Studied groups A little bad No change A little good Relative improvement Complete improvement P valuea
30minutes after consumption
ZMB 1 (1.3) 11 (13.9) 44 (55.7) 23 (29.1) 0
0.80Garlic 0 7 (9) 57 (73.1) 13 (16.7) 1(1.3)
Clotrimazole 0 7 (9) 54 (69.2) 17 (21.8) 0
Second night
ZMB 1 (1.3) 6 (7.6) 41 (51.9) 31 (39.2) 0
0.20Garlic 0 7 (9) 51 (65.4) 20 (25.6) 0
Clotrimazole 0 6 (7.7) 48 (61.5) 23 (29.5) 1 (1.3)
Third night
ZMB 0 3 (3.8) 13 (16.5) 61 (77.2) 2 (2.5)
0.50Garlic 0 0 58 (74.4) 19 (24.4) 1 (1.3)
Clotrimazole 0 17 (21.8) 58 (74.4) 3 (3.8) 0
Fourth night
ZMB 0 0 8 (10.1) 53 (67.1) 18 (22.8)
0.06Garlic 0 0 7 (9) 62 (79.5) 9 (11,5)
Clotrimazole 0 0 6 (7.7) 56 (71.8) 16 (20.5)
Fifth night
ZMB 0 0 2 (2.5) 30 (38) 47 (59.5)
0.25Garlic 0 0 58 (74.4) 39 (50) 38 (48.7)
Clotrimazole 0 0 0 34 (43.6) 44 (56.4)
Sixth night
ZMB 0 0 1 (1.3) 16 (20.3) 62 (78.5)
0.88Garlic 0 0 0 17 (21.8) 61 (78.2)
Clotrimazole 0 0 0 14 (17.9) 64 (82.1)
Seventh night
ZMB 0 1 (1.3) 1 (1.3) 13 (16.5) 64 (81)
0.21Garlic 0 0 0 16 (20.5) 62 (79.5)
Clotrimazole 1 (1.3) 0 0 13 (16.7) 64 (82.1)
Abbreviation: ZMB, Zataria multifloraboiss.
a Kruskal-Wallis test.
not had enough time for long time follow up of patients
and possible loss of participants, and, also, the severity of
the symptoms was reported based on clinical examination.
Virgins were excluded from this study. According to sev-
eral researchers, there is likelihood of transmission of the
microbes from the intestine to vagina, especially in cases
of recurrent candidal vaginitis and it is particularly recom-
mended to further study intestinal microorganisms (27).
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Table 5. Comparison of the Mean (SD) Scores of Candidal Vaginitis Symptoms at Baseline, days 7 and 30 After Interventiona
Before Intervention After Intervention
1 2 3 P* P** P**
7 Days After Intervention 30 Days After Intervention 1× 2 2× 3
Intervention Garlic 11.23 (2.01) 1.79 (1.29) 0.01 (-0.11) < 0.001 < 0.001 < 0.001
ZMB 11.23 (1.87) 1.07 (1.25) 0.03 (-0.25)
Control Clotrimazole 11.02 (2.00) 1.35 (1.32) 0/02 (-0.22) < 0.001 < 0.001 < 0.001
AdjustedMD (CI 95%) Clotrimazole and garlic 0.26 (-1.01 - 0.46) -0.34 (-0.83 - 0.13) 0.012 (-0.06 - 0.09) < 0.001 < 0.001 < 0.001
Pb 0.66 0.09 0.92
AdjustedMD (CI 95%)c Clotrimazole and ZMB 0.21 (0.51 - 0.94-) -0.43 (0.51 - 0.09-) 0.01 (0.065 - 0.09-)
Pb 0.77 0.21 0.93
Pd 0.66** 0.08** 0.75**
Abbreviation: MD, Mean Difference; ZMB, Zataria multifloraboiss.
a **, ANOVA with repeated measure (1× 2) before intervention and 7 days after intervention (2× 3) 7 days and 30 days after intervention after intervention.
b Tukey test for ANOVA.
c Adjusted mean difference.
d One-way ANOVA for comparing three groups.
Garlic and ZMB vaginal cream 2% is effective in the
treatment of candidal vaginitis, prevention of recurrence
after 30 days and improvement of clinical symptoms and
signs. Consequently, it can be an effective treatment option
in cases of drug resistance and in cases where subjects pre-
fer treatment with herbal medicines.
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